First Time Loading...

ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.07 AUD -1.41% Market Closed
Updated: Jun 8, 2024

Net Margin
ImpediMed Ltd

-185.5%
Current
-212%
Average
2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-185.5%
=
Net Income
-19.4m
/
Revenue
10.5m

Net Margin Across Competitors

Country AU
Market Cap 141.6m AUD
Net Margin
-185%
Country US
Market Cap 215.1B USD
Net Margin
21%
Country US
Market Cap 187.1B USD
Net Margin
14%
Country US
Market Cap 148.1B USD
Net Margin
27%
Country US
Market Cap 133.1B USD
Net Margin
16%
Country US
Market Cap 113.4B USD
Net Margin
12%
Country IE
Market Cap 110.2B USD
Net Margin
11%
Country US
Market Cap 69.9B USD
Net Margin
7%
Country DE
Market Cap 61.6B EUR
Net Margin
8%
Country US
Market Cap 53.1B USD
Net Margin
23%
Country CN
Market Cap 362.5B CNY
Net Margin
34%

Profitability Report

View the profitability report to see the full profitability analysis for ImpediMed Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-185.5%
=
Net Income
-19.4m
/
Revenue
10.5m
What is the Net Margin of ImpediMed Ltd?

Based on ImpediMed Ltd's most recent financial statements, the company has Net Margin of -185.5%.